GLA
IART icon

Great Lakes Advisors’s Integra LifeSciences IART Stock Holding History

Great Lakes Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,004
Closed -$229K – 793
2023
Q3 		$229K Buy
+6,004
New +$253K ﹤0.01% 700
2023
Q2 		– Sell
-182,968
Closed -$10.5M – 797
2023
Q1 		$10.5M Sell
182,968
-7,185
-4% -$405K 0.1% 206
2022
Q4 		$1.07M Buy
+190,153
New +$9.68M 0.06% 409
2022
Q3 		– Sell
-73,808
Closed -$3.99M – 669
2022
Q2 		$3.99M Sell
73,808
-1,380
-2% -$82.9K 0.08% 260
2022
Q1 		$4.83M Sell
75,188
-89,162
-54% -$5.87M 0.08% 247
2021
Q4 		$11M Sell
164,350
-3,541
-2% -$240K 0.17% 167
2021
Q3 		$11.5M Buy
+167,891
New +$11.9M 0.18% 166
2019
Q1 		– Sell
-106,808
Closed -$4.82M – 592
2018
Q4 		$4.82M Buy
106,808
+19,800
+23% +$1.09M 0.11% 198
2018
Q3 		$5.73M Sell
87,008
-11,248
-11% -$699K 0.13% 167
2018
Q2 		$6.33M Sell
98,256
-159
-0.2% -$9.85K 0.15% 155
2018
Q1 		$5.45M Sell
98,415
-101,250
-51% -$5.31M 0.13% 169
2017
Q4 		$9.56M Buy
199,665
+29,642
+17% +$1.45M 0.21% 89
2017
Q3 		$8.58M Buy
170,023
+10,866
+7% +$558K 0.2% 85
2017
Q2 		$8.68M Buy
159,157
+28,107
+21% +$1.34M 0.21% 82
2017
Q1 		$5.52M Buy
131,050
+20,266
+18% +$866K 0.14% 128
2016
Q4 		$4.75M Buy
110,784
+336
+0.3% +$13.7K 0.12% 139
2016
Q3 		$4.56M Sell
110,448
-27,158
-20% -$1.14M 0.12% 134
2016
Q2 		$5.49M Buy
137,606
+1,626
+1% +$58.5K 0.15% 116
2016
Q1 		$4.58M Buy
135,980
+21,156
+18% +$659K 0.13% 145
2015
Q4 		$3.89M Buy
114,824
+11,188
+11% +$350K 0.12% 160
2015
Q3 		$3.09M Buy
103,636
+17,014
+20% +$532K 0.1% 180
2015
Q2 		$2.38M Sell
86,622
-3,790
-4% -$101K 0.07% 212
2015
Q1 		$2.28M Sell
90,412
-22,348
-20% -$528K 0.07% 212
2014
Q4 		$2.5M Buy
112,760
+7,082
+7% +$144K 0.08% 187
2014
Q3 		$2.14M Buy
+105,678
New +$2.1M 0.07% 190

Other funds holding IART

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Great Lakes Advisors's IART Position: Q4 2023 in Review

Great Lakes Advisors sold out of Integra LifeSciences (IART) in Q4 2023, closing a stake of 6,004 shares — an estimated $229K sold.

Great Lakes Advisors first reported a position in IART in Q3 2014 and held it in 25 quarters. The position peaked at $11.5M in Q3 2021. 284 funds tracked by Wall St. Rank hold IART as of Q4 2023.

  • Great Lakes Advisors reported no remaining Integra LifeSciences position as of Q4 2023 after selling out during the quarter.
  • Great Lakes Advisors sold 6,004 Integra LifeSciences shares in Q4 2023, an estimated $229K.
  • Great Lakes Advisors first reported a position in Integra LifeSciences in Q3 2014 and held it in 25 quarters.
  • Great Lakes Advisors's Integra LifeSciences position peaked at $11.5M in Q3 2021.
  • 284 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2023.

Based on Great Lakes Advisors's 13F filing for Q4 2023, filed 8 Feb 2024.